Celldex Therapeutics Files 8-K on Financials
Ticker: CLDX · Form: 8-K · Filed: Aug 7, 2025 · CIK: 744218
| Field | Detail |
|---|---|
| Company | Celldex Therapeutics, Inc. (CLDX) |
| Form Type | 8-K |
| Filed Date | Aug 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
TL;DR
Celldex dropped an 8-K on financials, check it out.
AI Summary
Celldex Therapeutics, Inc. filed an 8-K on August 7, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits. The company, formerly known as AVANT IMMUNOTHERAPEUTICS INC and T CELL SCIENCES INC, is incorporated in Delaware and headquartered in Hampton, New Jersey.
Why It Matters
This filing provides investors with crucial updates on Celldex Therapeutics' financial health and operational performance, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Celldex Therapeutics, Inc. (company) — Registrant
- AVANT IMMUNOTHERAPEUTICS INC (company) — Former company name
- T CELL SCIENCES INC (company) — Former company name
- August 7, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Celldex Therapeutics, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on August 7, 2025.
What are the former names of Celldex Therapeutics, Inc. mentioned in the filing?
The former names of Celldex Therapeutics, Inc. mentioned in the filing are AVANT IMMUNOTHERAPEUTICS INC and T CELL SCIENCES INC.
In which state is Celldex Therapeutics, Inc. incorporated?
Celldex Therapeutics, Inc. is incorporated in Delaware.
What is the business address of Celldex Therapeutics, Inc.?
The business address of Celldex Therapeutics, Inc. is Perryville III Building, 53 Frontage Road, Suite 220, Hampton, New Jersey 08827.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 7, 2025 regarding Celldex Therapeutics, Inc. (CLDX).